<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty-five patients with localized non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of unfavorable histologic type (41 patients had diffuse histiocytic, 2 had nodular mixed, and 2 had minimally nodular histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) were treated with initial chemotherapy (28 patients), including <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, adriamycin, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi> (CHOP), or with initial CHOP followed by involved field radiotherapy (17 patients) </plain></SENT>
<SENT sid="1" pm="."><plain>Patients were clinically staged and found to have stage I (7 patients), stage IE (8), stage II (12), and stage IIE (18) </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the presence of potentially adverse prognostic factors, including age older than 65 yr (11 patients), bulky disease (17), gastrointestinal involvement (9), and "B" symptoms (4), 44 of 45 patients (98%) achieved a complete response </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-two patients (93%) are alive with a median follow-up time of 41 mo (range 3-128 mo) </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-eight patients (84%) remain continuously free of disease </plain></SENT>
<SENT sid="5" pm="."><plain>Neither the pretreatment clinical features nor the type of treatment significantly influenced the outcome for patients treated with initial chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>Patients who failed treatment relapsed at distant sites or in initially involved sites whether or not they received radiotherapy </plain></SENT>
<SENT sid="7" pm="."><plain>Initial treatment for localized <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of unfavorable histology with chemotherapy regimens of proven curative potential in advanced disease is a successful treatment strategy and obviates the need for extensive staging </plain></SENT>
<SENT sid="8" pm="."><plain>The role of involved field radiotherapy following initial chemotherapy needs to be defined </plain></SENT>
</text></document>